Jessica A. Hellyer

1.3k total citations
29 papers, 738 citations indexed

About

Jessica A. Hellyer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Jessica A. Hellyer has authored 29 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Jessica A. Hellyer's work include Lung Cancer Treatments and Mutations (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Myasthenia Gravis and Thymoma (5 papers). Jessica A. Hellyer is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Myasthenia Gravis and Thymoma (5 papers). Jessica A. Hellyer collaborates with scholars based in United States, France and Spain. Jessica A. Hellyer's co-authors include Heather A. Wakelee, Sukhmani K. Padda, Maximilian Diehn, Joel W. Neal, Kavitha Ramchandran, Millie Das, Henning Stehr, Jacqueline V. Aredo, Jonathan W. Riess and Youngtae Jeong and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and The American Journal of Cardiology.

In The Last Decade

Jessica A. Hellyer

29 papers receiving 731 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jessica A. Hellyer 316 309 235 148 133 29 738
Aurélie Catteau 304 1.0× 79 0.3× 536 2.3× 113 0.8× 22 0.2× 27 854
Dorothy T. Pei 150 0.5× 37 0.1× 229 1.0× 103 0.7× 29 0.2× 10 543
Wen-Qing Huang 95 0.3× 87 0.3× 353 1.5× 119 0.8× 21 0.2× 39 673
Isaac Rosa 63 0.2× 61 0.2× 288 1.2× 91 0.6× 147 1.1× 20 556
Anna Guadall 54 0.2× 120 0.4× 315 1.3× 82 0.6× 109 0.8× 20 633
Rosario Serrano 80 0.3× 45 0.1× 180 0.8× 63 0.4× 48 0.4× 26 430
Paula Rambarat 243 0.8× 78 0.3× 197 0.8× 19 0.1× 195 1.5× 15 566
Zhipeng Wen 44 0.1× 60 0.2× 159 0.7× 109 0.7× 41 0.3× 34 428
Nicole Clarke 170 0.5× 87 0.3× 204 0.9× 91 0.6× 15 0.1× 12 497
Katsusuke Kyotani 40 0.1× 57 0.2× 196 0.8× 172 1.2× 114 0.9× 27 547

Countries citing papers authored by Jessica A. Hellyer

Since Specialization
Citations

This map shows the geographic impact of Jessica A. Hellyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica A. Hellyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica A. Hellyer more than expected).

Fields of papers citing papers by Jessica A. Hellyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessica A. Hellyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica A. Hellyer. The network helps show where Jessica A. Hellyer may publish in the future.

Co-authorship network of co-authors of Jessica A. Hellyer

This figure shows the co-authorship network connecting the top 25 collaborators of Jessica A. Hellyer. A scholar is included among the top collaborators of Jessica A. Hellyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessica A. Hellyer. Jessica A. Hellyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gajra, Ajeet, Sibel Blau, Julio A. Peguero, et al.. (2024). Impact of Exigent Research Network’s partnership with the Tempus AI TIME Program on the screening and matching of patients for clinical trials.. Journal of Clinical Oncology. 42(16_suppl). e13599–e13599. 1 indexed citations
2.
Fayette, Jérôme, Florian Clatot, Irene Braña, et al.. (2024). Petosemtamab (MCLA-158) with pembrolizumab as first-line (1L) treatment of recurrent/metastatic (r/m) head and neck squamous cell carcinoma (HNSCC): Phase 2 study.. Journal of Clinical Oncology. 42(16_suppl). 6014–6014. 12 indexed citations
3.
Wu, Julie, Victoria Y. Ding, Sophia J. Luo, et al.. (2022). Predictive Model to Guide Brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung Cancer: Impact on Real-World Outcomes. JCO Precision Oncology. 6(6). e2200220–e2200220. 4 indexed citations
4.
Hellyer, Jessica A., et al.. (2022). Autoimmune Disease in Patients With Advanced Thymic Epithelial Tumors. JTO Clinical and Research Reports. 3(5). 100323–100323. 5 indexed citations
5.
Hellyer, Jessica A., Rebecca M. Gardner, Kristen Cunanan, et al.. (2021). Impact of Tumor Suppressor Gene Co-Mutations on Differential Response to EGFR TKI Therapy in EGFR L858R and Exon 19 Deletion Lung Cancer. Clinical Lung Cancer. 23(3). 264–272. 17 indexed citations
6.
Foggetti, Giorgia, Chuan Li, Hongchen Cai, et al.. (2021). Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo. Cancer Discovery. 11(7). 1736–1753. 68 indexed citations
7.
Aredo, Jacqueline V., Isa Mambetsariev, Jessica A. Hellyer, et al.. (2021). Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy. Journal of Thoracic Oncology. 16(6). 1030–1041. 86 indexed citations
8.
Hellyer, Jessica A., Jacqueline V. Aredo, Millie Das, et al.. (2021). Role of Consolidation Durvalumab in Patients With EGFR- and HER2-Mutant Unresectable Stage III NSCLC. Journal of Thoracic Oncology. 16(5). 868–872. 43 indexed citations
9.
Aredo, Jacqueline V., Jessica A. Hellyer, Joel W. Neal, et al.. (2021). MO01.01 Durvalumab for Patients with Stage III EGFR-Mutated Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy. Journal of Thoracic Oncology. 16(1). S15–S15. 1 indexed citations
10.
Hellyer, Jessica A., Madhu M. Ouseph, Sukhmani K. Padda, & Heather A. Wakelee. (2020). Everolimus in the treatment of metastatic thymic epithelial tumors. Lung Cancer. 149. 97–102. 12 indexed citations
11.
Hellyer, Jessica A., Sukhmani K. Padda, Maximilian Diehn, & Heather A. Wakelee. (2020). Clinical Implications of KEAP1-NFE2L2 Mutations in NSCLC. Journal of Thoracic Oncology. 16(3). 395–403. 39 indexed citations
12.
Hellyer, Jessica A. & Heather A. Wakelee. (2020). Adjuvant Chemotherapy. Thoracic surgery clinics/Thorac. surg. clin.. 30(2). 179–185. 3 indexed citations
13.
Jeong, Youngtae, Jessica A. Hellyer, Henning Stehr, et al.. (2019). Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non–Small Cell Lung Cancer. Clinical Cancer Research. 26(1). 274–281. 80 indexed citations
14.
Hellyer, Jessica A., Matthew A. Gubens, Kristen Cunanan, et al.. (2019). Phase II trial of single agent amrubicin in patients with previously treated advanced thymic malignancies. Lung Cancer. 137. 71–75. 11 indexed citations
15.
Hellyer, Jessica A. & Heather A. Wakelee. (2019). MS04.03 Adjuvant PD-(L)1 Checkpoint Inhibitors. Journal of Thoracic Oncology. 14(10). S156–S157. 1 indexed citations
16.
Hellyer, Jessica A., Henning Stehr, Millie Das, et al.. (2019). Impact of KEAP1/NFE2L2/CUL3 mutations on duration of response to EGFR tyrosine kinase inhibitors in EGFR mutated non-small cell lung cancer. Lung Cancer. 134. 42–45. 34 indexed citations
17.
Shafiq, Mājid, Maurice L. Druzin, Michael Jeng, et al.. (2016). Pregnancy Complicated by Gorham–Stout Disease and Refractory Chylothorax. American Journal of Perinatology Reports. 6(4). e355–e358. 4 indexed citations
18.
Hellyer, Jessica A., Farnaz Azarbal, Claire T. Than, et al.. (2016). Impact of Baseline Stroke Risk and Bleeding Risk on Warfarin International Normalized Ratio Control in Atrial Fibrillation (from the TREAT-AF Study). The American Journal of Cardiology. 119(2). 268–274. 12 indexed citations
19.
Hellyer, Jessica A., Alex Y. Tan, Kathleen A. Lane, et al.. (2013). Autonomic nerve activity and blood pressure in ambulatory dogs. Heart Rhythm. 11(2). 307–313. 7 indexed citations
20.
Maskoun, Waddah, Jessica A. Hellyer, Jheel Patel, et al.. (2012). Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation. Heart Rhythm. 10(4). 585–591. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aurélie Catteau Breakdown of academic impact, for papers by Dorothy T. Pei Breakdown of academic impact, for papers by Wen-Qing Huang Breakdown of academic impact, for papers by Isaac Rosa Breakdown of academic impact, for papers by Anna Guadall Breakdown of academic impact, for papers by Rosario Serrano Breakdown of academic impact, for papers by Paula Rambarat Breakdown of academic impact, for papers by Zhipeng Wen Breakdown of academic impact, for papers by Nicole Clarke Breakdown of academic impact, for papers by Katsusuke Kyotani
Rankless by CCL
2026